The ophthalmic drug packaging market had an estimated market share worth USD 276 million in 2023, and it is predicted to reach a global market valuation of USD 527.8 million by 2034, growing at a CAGR of 6.1% from 2024 to 2034.
Report Attribute | Details |
---|---|
Estimated Market Value in 2023 | USD 276 million |
Expected Market Value in 2024 | USD 292.2 million |
Projected Forecast Value in 2034 | USD 527.8 million |
Anticipated Growth Rate from 2024 to 2034 | 6.1% |
The global demand for the ophthalmic drug packaging market was estimated to reach a valuation of USD 222.3 million in 2019, according to a report from Future Market Insights (FMI). From 2019 to 2023, the ophthalmic drug packaging market witnesses significant growth, registering a CAGR of 5.6%.
Historical CAGR 2019 to 2023 | 5.6% |
---|---|
Forecast CAGR 2024 to 2034 | 6.1% |
The development of intelligent packaging solutions with digital technology integrated is one advancement in the ophthalmic drug packaging market. Electronic sensors, RFID (Radio Frequency Identification) tags, or NFC (Near Field Communication) chips are a few examples of features that these smart packages may include.
These capabilities allow for real time monitoring of drug consumption, temperature, and expiration dates. By giving patients dose reminders and tracking, this invention improves drug adherence. It also gives healthcare practitioners useful data to assess treatment progress and improve patient outcomes. Such innovations are anticipated to push the market growth forward.
Personalized Therapies and Precision Medicine to Enhance Growth
One distinct factor propelling the ophthalmic drug packaging market is the increasing prevalence of precision medicines and customized medicine. The need for personalized ophthalmic drugs that are matched to each patient's unique profile is rising due to developments in genetic testing and targeted therapies. This trend necessitates creative packaging options that maintain accuracy and safety while enabling a range of doses, formulations, and administration schedules.
Personalized medicine also encourages pharmaceutical firms and package manufacturers to work together to create customized packaging forms that improve patient outcomes and drug efficacy. This driver is a reflection of the way that healthcare is changing to provide more individualized treatment, which is encouraging innovation in the packaging of ophthalmic drugs.
Quality Control and Supply Chain Disruptions to Impede the Market Growth
Few restraints of the market are:
This section focuses on providing detailed analysis of two particular market segments for ophthalmic drug packaging, the dominant dose type and the significant end use. The two main segments discussed below are the IVD equipment and immunoassay.
Dose Type | Multi Dose |
---|---|
Market Share in 2024 | 81.7% |
The multi dose drug segment is anticipated to reach an 81.7% market share in 2024. Many eye disorders need frequent and long term therapy, making multidose packaging affordable and easy for patients. Since these drugs are usually taken in small amounts, dispensing several doses from a single container is feasible.
The use of multidose packaging improves patient outcomes and treatment efficacy by making it simpler for patients and healthcare professionals to keep track of medicine consumption and adherence.
Preservatives and antibacterial agents are frequently included in multi dose packaging for ocular medications in order to preserve sterility and avoid contamination over the course of therapy.
End Use | Prescription |
---|---|
Market Share in 2024 | 64.2% |
In 2024, the prescription segment by end use is likely to gain a 64.2% market share. Ophthalmic drug packaging is mostly utilized for prescription medication since eye treatments are specialized. Prescription drugs frequently need exact dosage and administration guidelines catered to the specific requirements of each patient, therefore packaging designs that guarantee right delivery and save waste are required.
Specialist packaging is necessary to ensure therapeutic efficacy and safety for patients under professional medical care. This is because prescription ophthalmic drugs may include strong or delicate chemicals that need extra protection against contamination and degradation.
This section will go into detail on the ophthalmic drug packaging markets in a few key countries, including the United States, the United Kingdom, China, Japan and South Korea. This segment will focus on the key factors that are driving up demand in these countries for ophthalmic drug packaging.
Countries | Forecast CAGR from 2024 to 2034 |
---|---|
The United States | 11.9% |
The United Kingdom | 12.9% |
China | 12.7% |
Japan | 13% |
South Korea | 14.1% |
The United States ophthalmic drug packaging ecosystem is anticipated to gain a CAGR of 4.3% through 2034. Factors that are bolstering the growth are:
The ophthalmic drug packaging market in the United Kingdom is expected to expand with a 5.5% CAGR through 2034. The factors pushing the growth are:
The ophthalmic drug packaging ecosystem in China is anticipated to develop with a 7.1% CAGR from 2024 to 2034. The drivers behind this growth are:
The ophthalmic drug packaging industry in Japan is anticipated to reach a 4.4% CAGR from 2024 to 2034. The drivers propelling growth forward are:
The ophthalmic drug packaging ecosystem in South Korea is likely to evolve with a 5.6% CAGR during the forecast period. The factors bolstering the growth are:
Companies are realizing how crucial it is to develop specialized packaging solutions to satisfy the various demands of healthcare professionals and patients. This might entail specially designed package formats, including pre filled syringes, multi dose bottles, or single dose vials, in addition to packaging designs that promote patient adherence and convenience of use. In the pharmaceutical sector, compliance with strict regulations is essential, especially when it comes to the packaging of ophthalmic drugs.
To guarantee product safety and market approval, leading companies place a high priority on adhering to rules established by regulatory authorities like the European Medicines Agency (EMA) in Europe and the Food and Drug Administration (FDA) in the United States. Continual research and development is necessary to propel innovation in the packaging of ophthalmic drugs. The key players in this market include:
Significant advancements in the ophthalmic drug packaging market are being made by key market participants, and these include:
Report Attribute | Details |
---|---|
Growth Rate | CAGR of 6.1% from 2024 to 2034 |
Market value in 2024 | USD 292.2 million |
Market value in 2034 | USD 527.8 million |
Base Year for Estimation | 2023 |
Historical Data | 2019 to 2023 |
Forecast Period | 2024 to 2034 |
Quantitative Units | USD million for value |
Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
Segments Covered | Dose, Material Type, End Use, End User |
Regions Covered | North America; Latin America; Western Europe; Eastern Europe; South Asia and Pacific; East Asia; The Middle East & Africa |
Countries Profiled | The United States, Canada, Brazil, Mexico, Germany, The United Kingdom, France, Spain, Italy, Poland, Russia, Czech Republic, Romania, India, Bangladesh, Australia, New Zealand, China, Japan, South Korea, GCC Countries, South Africa, Israel |
Key Companies Profiled | Amcor; West Pharmaceutical Services Inc.; Gerresheimer AG; Merck Sharp & Dohme Corp.; AptarGroup Inc.; Akorn Inc.; Mitotech SA; Bausch & Lomb Incorporated; Bayer AG; Novartis AG |
Customization Scope | Available on Request |
Table 1: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034
Table 2: Global Market Volume (Units) Forecast by Region, 2019 to 2034
Table 3: Global Market Value (US$ Million) Forecast by Dose, 2019 to 2034
Table 4: Global Market Volume (Units) Forecast by Dose, 2019 to 2034
Table 5: Global Market Value (US$ Million) Forecast by Material Type, 2019 to 2034
Table 6: Global Market Volume (Units) Forecast by Material Type, 2019 to 2034
Table 7: Global Market Value (US$ Million) Forecast by End Use, 2019 to 2034
Table 8: Global Market Volume (Units) Forecast by End Use, 2019 to 2034
Table 9: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 10: North America Market Volume (Units) Forecast by Country, 2019 to 2034
Table 11: North America Market Value (US$ Million) Forecast by Dose, 2019 to 2034
Table 12: North America Market Volume (Units) Forecast by Dose, 2019 to 2034
Table 13: North America Market Value (US$ Million) Forecast by Material Type, 2019 to 2034
Table 14: North America Market Volume (Units) Forecast by Material Type, 2019 to 2034
Table 15: North America Market Value (US$ Million) Forecast by End Use, 2019 to 2034
Table 16: North America Market Volume (Units) Forecast by End Use, 2019 to 2034
Table 17: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 18: Latin America Market Volume (Units) Forecast by Country, 2019 to 2034
Table 19: Latin America Market Value (US$ Million) Forecast by Dose, 2019 to 2034
Table 20: Latin America Market Volume (Units) Forecast by Dose, 2019 to 2034
Table 21: Latin America Market Value (US$ Million) Forecast by Material Type, 2019 to 2034
Table 22: Latin America Market Volume (Units) Forecast by Material Type, 2019 to 2034
Table 23: Latin America Market Value (US$ Million) Forecast by End Use, 2019 to 2034
Table 24: Latin America Market Volume (Units) Forecast by End Use, 2019 to 2034
Table 25: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 26: Western Europe Market Volume (Units) Forecast by Country, 2019 to 2034
Table 27: Western Europe Market Value (US$ Million) Forecast by Dose, 2019 to 2034
Table 28: Western Europe Market Volume (Units) Forecast by Dose, 2019 to 2034
Table 29: Western Europe Market Value (US$ Million) Forecast by Material Type, 2019 to 2034
Table 30: Western Europe Market Volume (Units) Forecast by Material Type, 2019 to 2034
Table 31: Western Europe Market Value (US$ Million) Forecast by End Use, 2019 to 2034
Table 32: Western Europe Market Volume (Units) Forecast by End Use, 2019 to 2034
Table 33: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 34: Eastern Europe Market Volume (Units) Forecast by Country, 2019 to 2034
Table 35: Eastern Europe Market Value (US$ Million) Forecast by Dose, 2019 to 2034
Table 36: Eastern Europe Market Volume (Units) Forecast by Dose, 2019 to 2034
Table 37: Eastern Europe Market Value (US$ Million) Forecast by Material Type, 2019 to 2034
Table 38: Eastern Europe Market Volume (Units) Forecast by Material Type, 2019 to 2034
Table 39: Eastern Europe Market Value (US$ Million) Forecast by End Use, 2019 to 2034
Table 40: Eastern Europe Market Volume (Units) Forecast by End Use, 2019 to 2034
Table 41: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 42: South Asia and Pacific Market Volume (Units) Forecast by Country, 2019 to 2034
Table 43: South Asia and Pacific Market Value (US$ Million) Forecast by Dose, 2019 to 2034
Table 44: South Asia and Pacific Market Volume (Units) Forecast by Dose, 2019 to 2034
Table 45: South Asia and Pacific Market Value (US$ Million) Forecast by Material Type, 2019 to 2034
Table 46: South Asia and Pacific Market Volume (Units) Forecast by Material Type, 2019 to 2034
Table 47: South Asia and Pacific Market Value (US$ Million) Forecast by End Use, 2019 to 2034
Table 48: South Asia and Pacific Market Volume (Units) Forecast by End Use, 2019 to 2034
Table 49: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 50: East Asia Market Volume (Units) Forecast by Country, 2019 to 2034
Table 51: East Asia Market Value (US$ Million) Forecast by Dose, 2019 to 2034
Table 52: East Asia Market Volume (Units) Forecast by Dose, 2019 to 2034
Table 53: East Asia Market Value (US$ Million) Forecast by Material Type, 2019 to 2034
Table 54: East Asia Market Volume (Units) Forecast by Material Type, 2019 to 2034
Table 55: East Asia Market Value (US$ Million) Forecast by End Use, 2019 to 2034
Table 56: East Asia Market Volume (Units) Forecast by End Use, 2019 to 2034
Table 57: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 58: Middle East and Africa Market Volume (Units) Forecast by Country, 2019 to 2034
Table 59: Middle East and Africa Market Value (US$ Million) Forecast by Dose, 2019 to 2034
Table 60: Middle East and Africa Market Volume (Units) Forecast by Dose, 2019 to 2034
Table 61: Middle East and Africa Market Value (US$ Million) Forecast by Material Type, 2019 to 2034
Table 62: Middle East and Africa Market Volume (Units) Forecast by Material Type, 2019 to 2034
Table 63: Middle East and Africa Market Value (US$ Million) Forecast by End Use, 2019 to 2034
Table 64: Middle East and Africa Market Volume (Units) Forecast by End Use, 2019 to 2034
Figure 1: Global Market Value (US$ Million) by Dose, 2024 to 2034
Figure 2: Global Market Value (US$ Million) by Material Type, 2024 to 2034
Figure 3: Global Market Value (US$ Million) by End Use, 2024 to 2034
Figure 4: Global Market Value (US$ Million) by Region, 2024 to 2034
Figure 5: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034
Figure 6: Global Market Volume (Units) Analysis by Region, 2019 to 2034
Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034
Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034
Figure 9: Global Market Value (US$ Million) Analysis by Dose, 2019 to 2034
Figure 10: Global Market Volume (Units) Analysis by Dose, 2019 to 2034
Figure 11: Global Market Value Share (%) and BPS Analysis by Dose, 2024 to 2034
Figure 12: Global Market Y-o-Y Growth (%) Projections by Dose, 2024 to 2034
Figure 13: Global Market Value (US$ Million) Analysis by Material Type, 2019 to 2034
Figure 14: Global Market Volume (Units) Analysis by Material Type, 2019 to 2034
Figure 15: Global Market Value Share (%) and BPS Analysis by Material Type, 2024 to 2034
Figure 16: Global Market Y-o-Y Growth (%) Projections by Material Type, 2024 to 2034
Figure 17: Global Market Value (US$ Million) Analysis by End Use, 2019 to 2034
Figure 18: Global Market Volume (Units) Analysis by End Use, 2019 to 2034
Figure 19: Global Market Value Share (%) and BPS Analysis by End Use, 2024 to 2034
Figure 20: Global Market Y-o-Y Growth (%) Projections by End Use, 2024 to 2034
Figure 21: Global Market Attractiveness by Dose, 2024 to 2034
Figure 22: Global Market Attractiveness by Material Type, 2024 to 2034
Figure 23: Global Market Attractiveness by End Use, 2024 to 2034
Figure 24: Global Market Attractiveness by Region, 2024 to 2034
Figure 25: North America Market Value (US$ Million) by Dose, 2024 to 2034
Figure 26: North America Market Value (US$ Million) by Material Type, 2024 to 2034
Figure 27: North America Market Value (US$ Million) by End Use, 2024 to 2034
Figure 28: North America Market Value (US$ Million) by Country, 2024 to 2034
Figure 29: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 30: North America Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 31: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 32: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 33: North America Market Value (US$ Million) Analysis by Dose, 2019 to 2034
Figure 34: North America Market Volume (Units) Analysis by Dose, 2019 to 2034
Figure 35: North America Market Value Share (%) and BPS Analysis by Dose, 2024 to 2034
Figure 36: North America Market Y-o-Y Growth (%) Projections by Dose, 2024 to 2034
Figure 37: North America Market Value (US$ Million) Analysis by Material Type, 2019 to 2034
Figure 38: North America Market Volume (Units) Analysis by Material Type, 2019 to 2034
Figure 39: North America Market Value Share (%) and BPS Analysis by Material Type, 2024 to 2034
Figure 40: North America Market Y-o-Y Growth (%) Projections by Material Type, 2024 to 2034
Figure 41: North America Market Value (US$ Million) Analysis by End Use, 2019 to 2034
Figure 42: North America Market Volume (Units) Analysis by End Use, 2019 to 2034
Figure 43: North America Market Value Share (%) and BPS Analysis by End Use, 2024 to 2034
Figure 44: North America Market Y-o-Y Growth (%) Projections by End Use, 2024 to 2034
Figure 45: North America Market Attractiveness by Dose, 2024 to 2034
Figure 46: North America Market Attractiveness by Material Type, 2024 to 2034
Figure 47: North America Market Attractiveness by End Use, 2024 to 2034
Figure 48: North America Market Attractiveness by Country, 2024 to 2034
Figure 49: Latin America Market Value (US$ Million) by Dose, 2024 to 2034
Figure 50: Latin America Market Value (US$ Million) by Material Type, 2024 to 2034
Figure 51: Latin America Market Value (US$ Million) by End Use, 2024 to 2034
Figure 52: Latin America Market Value (US$ Million) by Country, 2024 to 2034
Figure 53: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 54: Latin America Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 55: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 57: Latin America Market Value (US$ Million) Analysis by Dose, 2019 to 2034
Figure 58: Latin America Market Volume (Units) Analysis by Dose, 2019 to 2034
Figure 59: Latin America Market Value Share (%) and BPS Analysis by Dose, 2024 to 2034
Figure 60: Latin America Market Y-o-Y Growth (%) Projections by Dose, 2024 to 2034
Figure 61: Latin America Market Value (US$ Million) Analysis by Material Type, 2019 to 2034
Figure 62: Latin America Market Volume (Units) Analysis by Material Type, 2019 to 2034
Figure 63: Latin America Market Value Share (%) and BPS Analysis by Material Type, 2024 to 2034
Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Material Type, 2024 to 2034
Figure 65: Latin America Market Value (US$ Million) Analysis by End Use, 2019 to 2034
Figure 66: Latin America Market Volume (Units) Analysis by End Use, 2019 to 2034
Figure 67: Latin America Market Value Share (%) and BPS Analysis by End Use, 2024 to 2034
Figure 68: Latin America Market Y-o-Y Growth (%) Projections by End Use, 2024 to 2034
Figure 69: Latin America Market Attractiveness by Dose, 2024 to 2034
Figure 70: Latin America Market Attractiveness by Material Type, 2024 to 2034
Figure 71: Latin America Market Attractiveness by End Use, 2024 to 2034
Figure 72: Latin America Market Attractiveness by Country, 2024 to 2034
Figure 73: Western Europe Market Value (US$ Million) by Dose, 2024 to 2034
Figure 74: Western Europe Market Value (US$ Million) by Material Type, 2024 to 2034
Figure 75: Western Europe Market Value (US$ Million) by End Use, 2024 to 2034
Figure 76: Western Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 77: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 78: Western Europe Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 79: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 80: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 81: Western Europe Market Value (US$ Million) Analysis by Dose, 2019 to 2034
Figure 82: Western Europe Market Volume (Units) Analysis by Dose, 2019 to 2034
Figure 83: Western Europe Market Value Share (%) and BPS Analysis by Dose, 2024 to 2034
Figure 84: Western Europe Market Y-o-Y Growth (%) Projections by Dose, 2024 to 2034
Figure 85: Western Europe Market Value (US$ Million) Analysis by Material Type, 2019 to 2034
Figure 86: Western Europe Market Volume (Units) Analysis by Material Type, 2019 to 2034
Figure 87: Western Europe Market Value Share (%) and BPS Analysis by Material Type, 2024 to 2034
Figure 88: Western Europe Market Y-o-Y Growth (%) Projections by Material Type, 2024 to 2034
Figure 89: Western Europe Market Value (US$ Million) Analysis by End Use, 2019 to 2034
Figure 90: Western Europe Market Volume (Units) Analysis by End Use, 2019 to 2034
Figure 91: Western Europe Market Value Share (%) and BPS Analysis by End Use, 2024 to 2034
Figure 92: Western Europe Market Y-o-Y Growth (%) Projections by End Use, 2024 to 2034
Figure 93: Western Europe Market Attractiveness by Dose, 2024 to 2034
Figure 94: Western Europe Market Attractiveness by Material Type, 2024 to 2034
Figure 95: Western Europe Market Attractiveness by End Use, 2024 to 2034
Figure 96: Western Europe Market Attractiveness by Country, 2024 to 2034
Figure 97: Eastern Europe Market Value (US$ Million) by Dose, 2024 to 2034
Figure 98: Eastern Europe Market Value (US$ Million) by Material Type, 2024 to 2034
Figure 99: Eastern Europe Market Value (US$ Million) by End Use, 2024 to 2034
Figure 100: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 101: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 102: Eastern Europe Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 103: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 104: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 105: Eastern Europe Market Value (US$ Million) Analysis by Dose, 2019 to 2034
Figure 106: Eastern Europe Market Volume (Units) Analysis by Dose, 2019 to 2034
Figure 107: Eastern Europe Market Value Share (%) and BPS Analysis by Dose, 2024 to 2034
Figure 108: Eastern Europe Market Y-o-Y Growth (%) Projections by Dose, 2024 to 2034
Figure 109: Eastern Europe Market Value (US$ Million) Analysis by Material Type, 2019 to 2034
Figure 110: Eastern Europe Market Volume (Units) Analysis by Material Type, 2019 to 2034
Figure 111: Eastern Europe Market Value Share (%) and BPS Analysis by Material Type, 2024 to 2034
Figure 112: Eastern Europe Market Y-o-Y Growth (%) Projections by Material Type, 2024 to 2034
Figure 113: Eastern Europe Market Value (US$ Million) Analysis by End Use, 2019 to 2034
Figure 114: Eastern Europe Market Volume (Units) Analysis by End Use, 2019 to 2034
Figure 115: Eastern Europe Market Value Share (%) and BPS Analysis by End Use, 2024 to 2034
Figure 116: Eastern Europe Market Y-o-Y Growth (%) Projections by End Use, 2024 to 2034
Figure 117: Eastern Europe Market Attractiveness by Dose, 2024 to 2034
Figure 118: Eastern Europe Market Attractiveness by Material Type, 2024 to 2034
Figure 119: Eastern Europe Market Attractiveness by End Use, 2024 to 2034
Figure 120: Eastern Europe Market Attractiveness by Country, 2024 to 2034
Figure 121: South Asia and Pacific Market Value (US$ Million) by Dose, 2024 to 2034
Figure 122: South Asia and Pacific Market Value (US$ Million) by Material Type, 2024 to 2034
Figure 123: South Asia and Pacific Market Value (US$ Million) by End Use, 2024 to 2034
Figure 124: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034
Figure 125: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 126: South Asia and Pacific Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 127: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 128: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 129: South Asia and Pacific Market Value (US$ Million) Analysis by Dose, 2019 to 2034
Figure 130: South Asia and Pacific Market Volume (Units) Analysis by Dose, 2019 to 2034
Figure 131: South Asia and Pacific Market Value Share (%) and BPS Analysis by Dose, 2024 to 2034
Figure 132: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Dose, 2024 to 2034
Figure 133: South Asia and Pacific Market Value (US$ Million) Analysis by Material Type, 2019 to 2034
Figure 134: South Asia and Pacific Market Volume (Units) Analysis by Material Type, 2019 to 2034
Figure 135: South Asia and Pacific Market Value Share (%) and BPS Analysis by Material Type, 2024 to 2034
Figure 136: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Material Type, 2024 to 2034
Figure 137: South Asia and Pacific Market Value (US$ Million) Analysis by End Use, 2019 to 2034
Figure 138: South Asia and Pacific Market Volume (Units) Analysis by End Use, 2019 to 2034
Figure 139: South Asia and Pacific Market Value Share (%) and BPS Analysis by End Use, 2024 to 2034
Figure 140: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End Use, 2024 to 2034
Figure 141: South Asia and Pacific Market Attractiveness by Dose, 2024 to 2034
Figure 142: South Asia and Pacific Market Attractiveness by Material Type, 2024 to 2034
Figure 143: South Asia and Pacific Market Attractiveness by End Use, 2024 to 2034
Figure 144: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034
Figure 145: East Asia Market Value (US$ Million) by Dose, 2024 to 2034
Figure 146: East Asia Market Value (US$ Million) by Material Type, 2024 to 2034
Figure 147: East Asia Market Value (US$ Million) by End Use, 2024 to 2034
Figure 148: East Asia Market Value (US$ Million) by Country, 2024 to 2034
Figure 149: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 150: East Asia Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 151: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 152: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 153: East Asia Market Value (US$ Million) Analysis by Dose, 2019 to 2034
Figure 154: East Asia Market Volume (Units) Analysis by Dose, 2019 to 2034
Figure 155: East Asia Market Value Share (%) and BPS Analysis by Dose, 2024 to 2034
Figure 156: East Asia Market Y-o-Y Growth (%) Projections by Dose, 2024 to 2034
Figure 157: East Asia Market Value (US$ Million) Analysis by Material Type, 2019 to 2034
Figure 158: East Asia Market Volume (Units) Analysis by Material Type, 2019 to 2034
Figure 159: East Asia Market Value Share (%) and BPS Analysis by Material Type, 2024 to 2034
Figure 160: East Asia Market Y-o-Y Growth (%) Projections by Material Type, 2024 to 2034
Figure 161: East Asia Market Value (US$ Million) Analysis by End Use, 2019 to 2034
Figure 162: East Asia Market Volume (Units) Analysis by End Use, 2019 to 2034
Figure 163: East Asia Market Value Share (%) and BPS Analysis by End Use, 2024 to 2034
Figure 164: East Asia Market Y-o-Y Growth (%) Projections by End Use, 2024 to 2034
Figure 165: East Asia Market Attractiveness by Dose, 2024 to 2034
Figure 166: East Asia Market Attractiveness by Material Type, 2024 to 2034
Figure 167: East Asia Market Attractiveness by End Use, 2024 to 2034
Figure 168: East Asia Market Attractiveness by Country, 2024 to 2034
Figure 169: Middle East and Africa Market Value (US$ Million) by Dose, 2024 to 2034
Figure 170: Middle East and Africa Market Value (US$ Million) by Material Type, 2024 to 2034
Figure 171: Middle East and Africa Market Value (US$ Million) by End Use, 2024 to 2034
Figure 172: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034
Figure 173: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 174: Middle East and Africa Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 175: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 176: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 177: Middle East and Africa Market Value (US$ Million) Analysis by Dose, 2019 to 2034
Figure 178: Middle East and Africa Market Volume (Units) Analysis by Dose, 2019 to 2034
Figure 179: Middle East and Africa Market Value Share (%) and BPS Analysis by Dose, 2024 to 2034
Figure 180: Middle East and Africa Market Y-o-Y Growth (%) Projections by Dose, 2024 to 2034
Figure 181: Middle East and Africa Market Value (US$ Million) Analysis by Material Type, 2019 to 2034
Figure 182: Middle East and Africa Market Volume (Units) Analysis by Material Type, 2019 to 2034
Figure 183: Middle East and Africa Market Value Share (%) and BPS Analysis by Material Type, 2024 to 2034
Figure 184: Middle East and Africa Market Y-o-Y Growth (%) Projections by Material Type, 2024 to 2034
Figure 185: Middle East and Africa Market Value (US$ Million) Analysis by End Use, 2019 to 2034
Figure 186: Middle East and Africa Market Volume (Units) Analysis by End Use, 2019 to 2034
Figure 187: Middle East and Africa Market Value Share (%) and BPS Analysis by End Use, 2024 to 2034
Figure 188: Middle East and Africa Market Y-o-Y Growth (%) Projections by End Use, 2024 to 2034
Figure 189: Middle East and Africa Market Attractiveness by Dose, 2024 to 2034
Figure 190: Middle East and Africa Market Attractiveness by Material Type, 2024 to 2034
Figure 191: Middle East and Africa Market Attractiveness by End Use, 2024 to 2034
Figure 192: Middle East and Africa Market Attractiveness by Country, 2024 to 2034
The ophthalmic drug packaging market is expected to garner a 6.1% CAGR from 2024 to 2034.
By 2024, the global ophthalmic drug packaging market is likely to gain USD 292.2 million.
By 2034, the ophthalmic drug packaging market valuation is likely to reach USD 527.8 million.
The ophthalmic drug packaging industry in the United States is likely to progress at a 4.3% CAGR.
Multi dose is highly preferred in the ophthalmic drug packaging market and is likely to gain an 81.7% market share in 2024.
The prescription based ophthalmic drug packaging will gain traction in 2024, with an anticipated 64.2% market share.
Explore Similar Insights
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.